Our in vitro analysis validated that the chemosensitivity of LAT1-suppressed pancreatic cancer cells was higher than that of control cells, which was consistent with the expected LAT1 function in clinical pancreatic cancer [22]. This evidence concerns the gene SLC7A5 and pancreatic neoplasm.